Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rescue With Brentuximab Plus PD-1 Blockade Followed by Autotransplantation and Consolidation With Brentuximab Plus PD-1 Blockade in Patients With Relapsed/Refractory Hodgkin Lymphoma: Exploratory Single-arm Analysis

NCT05595447 is registered in ClinicalTrials.gov with Hospital Regional de Alta Especialidad del Bajio as lead sponsor.

NCT NCT05595447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rescue With Brentuximab Plus PD-1 Blockade Followed by Autotransplantation and Consolidation With Brentuximab Plus PD-1 Blockade in Patients With Relapsed/Refractory Hodgkin Lymphoma: Exploratory Single-arm Analysis
Lead sponsor
Hospital Regional de Alta Especialidad del Bajio
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 18, 2022
Completion date
October 18, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, refractory hodgkin lymphoma, relapsed hodgkin's disease, adult